447 related articles for article (PubMed ID: 23842708)
21. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
Raptis A; Duh MS; Wang ST; Dial E; Fanourgiakis I; Fortner B; Paley C; Mody-Patel N; Corral M; Scott J
Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I
Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540
[TBL] [Abstract][Full Text] [Related]
23. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
[TBL] [Abstract][Full Text] [Related]
24. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
Zaritsky J; Young B; Gales B; Wang HJ; Rastogi A; Westerman M; Nemeth E; Ganz T; Salusky IB
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1010-4. PubMed ID: 20299375
[TBL] [Abstract][Full Text] [Related]
25. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
26. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA
Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089
[TBL] [Abstract][Full Text] [Related]
27. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
[TBL] [Abstract][Full Text] [Related]
28. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children.
Aeberli I; Hurrell RF; Zimmermann MB
Int J Obes (Lond); 2009 Oct; 33(10):1111-7. PubMed ID: 19636315
[TBL] [Abstract][Full Text] [Related]
29. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload.
Fernández-Ruiz M; Parra P; Ruiz-Merlo T; López-Medrano F; San Juan R; Polanco N; González E; Andrés A; Aguado JM
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29120522
[TBL] [Abstract][Full Text] [Related]
30. Iron homeostasis and serum hepcidin-25 levels in obese children and adolescents: relation to body mass index.
Hamza RT; Hamed AI; Kharshoum RR
Horm Res Paediatr; 2013; 80(1):11-7. PubMed ID: 23817203
[TBL] [Abstract][Full Text] [Related]
31. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
[TBL] [Abstract][Full Text] [Related]
32. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
[TBL] [Abstract][Full Text] [Related]
33. Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.
Brătescu LO; Bârsan L; Gârneaţă L; Stanciu A; Lipan M; Stancu SH; Mircescu G
Int Urol Nephrol; 2014 May; 46(5):1005-12. PubMed ID: 24800994
[TBL] [Abstract][Full Text] [Related]
34. Hepcidin and iron deficiency in pre-kidney transplant patients.
Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
[TBL] [Abstract][Full Text] [Related]
35. Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome.
Ghoti H; Fibach E; Westerman M; Gordana O; Ganz T; Rachmilewitz EA
Br J Haematol; 2011 Apr; 153(1):118-20. PubMed ID: 21332711
[TBL] [Abstract][Full Text] [Related]
36. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
Malyszko J; Malyszko JS; Mysliwiec M
Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
[TBL] [Abstract][Full Text] [Related]
37. [Clinical study of iron metabolism indicators in ineffective hematopoiesis of myelodysplastic syndrome].
Yang Y; Yang B; Liang ZP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):948-52. PubMed ID: 23998591
[TBL] [Abstract][Full Text] [Related]
38. Serum Hepcidin Levels in Childhood-Onset Ischemic Stroke: A Case-Control Study.
Azab SF; Akeel NE; Abdalhady MA; Elhewala AA; Ali ASA; Amin EK; Sarhan DT; Almalky MAA; Elhindawy EM; Salam MMA; Soliman AA; Abdellatif SH; Ismail SM; Elsamad NA; Hashem MIA; Aziz KA; Elazouni OMA; Arafat MS
Medicine (Baltimore); 2016 Mar; 95(9):e2921. PubMed ID: 26945394
[TBL] [Abstract][Full Text] [Related]
39. Perinatal Factors Affecting Serum Hepcidin Levels in Low-Birth-Weight Infants.
Ichinomiya K; Maruyama K; Inoue T; Koizumi A; Inoue F; Fukuda K; Yamazaki Y; Arakawa H
Neonatology; 2017; 112(2):180-186. PubMed ID: 28601871
[TBL] [Abstract][Full Text] [Related]
40. Does hepcidin affect erythropoiesis in hemodialysis patients?
Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I
Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
